Caring for the Ages
December 30, 2016
Showing 6121 - 6130 of 8169 results
JAMDA
March 13, 2014
Psychotropic Drugs in Patients With Alzheimer's Disease: A Longitudinal Study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain
Psychotropic drugs are usually prescribed to deal with behavioral and psychological symptoms of dementia, especially when nonpharmacologic approaches are not available or have limited efficacy. Poor outcomes and serious adverse events of the drugs used must be addressed, and risk-benefit ratios need to be ...
JAMDA
February 25, 2016
Psychotropic Medication Usage and the Presence/Absence of Geriatric Psychiatry Services in Skilled Nursing Facilities
Caring for the Ages
October 30, 2015
Psychotropic Medications May Increase Risk of Death
Caring for the Ages
March 2, 2015
Psychotropic Risks Heightened in Patients With Dementia
JAMDA
October 17, 2023
Psychotropic, Anticonvulsant, and Opioid Use in Assisted Living Residents Before and During the COVID-19 Pandemic
To examine the associations between COVID-19 pandemic waves (1–4) and prevalent antipsychotic, antidepressant, benzodiazepine, anticonvulsant, and opioid use among assisted living (AL) residents, by setting (dementia care vs other).
Caring for the Ages
February 27, 2019
PTSD and Trauma-Informed Care in the Long-Term Care Setting
JAMDA
September 30, 2022
Public Quality Reporting and Nursing Home Admission Decisions
JAMDA
October 15, 2021
Public Reporting of Adverse Events From Long-Term Care Facilities for Older Persons and People With Disability in Ireland 2013-2019: Development of an Openly Accessible Database and Descriptive Analyses
To describe the development of an analyzable database of statutory notifications received from long-term care facilities (LTCFs) and to describe trends in receipt of notifications from 2013 to 2019.Landing Page